First and Best Treatments for EGFR and PD-L1 - Competition for First Line Therapy in Adenocarcinoma

MLA

Theodora Tsiouda, et al. “First and Best Treatments for EGFR and PD-L1 - Competition for First Line Therapy in Adenocarcinoma.” Oncomedicine, vol. 2, Jan. 2017, pp. 138–41. EBSCOhost, https://doi.org/10.7150/oncm.20759.

APA

Theodora Tsiouda, Paul Zarogoulidis, Lonny Yarmus, Theodora Kerenidi, Wolfgang Hohenforst-Schmidt, Haidong Huang, George Papatsibas, Chrisanthi Sardeli, Yan-Gao Man, Nikolaos Barbetakis, Christoforos Kosmidis, & Chong Bai. (2017). First and Best Treatments for EGFR and PD-L1 - Competition for First Line Therapy in Adenocarcinoma. Oncomedicine, 2, 138–141. https://doi.org/10.7150/oncm.20759

Chicago

Theodora Tsiouda, Paul Zarogoulidis, Lonny Yarmus, Theodora Kerenidi, Wolfgang Hohenforst-Schmidt, Haidong Huang, George Papatsibas, et al. 2017. “First and Best Treatments for EGFR and PD-L1 - Competition for First Line Therapy in Adenocarcinoma.” Oncomedicine 2 (January): 138–41. doi:10.7150/oncm.20759.